日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

瑞波替尼治疗ROS1融合阳性非小细胞肺癌

Drilon, Alexander; Camidge, D Ross; Lin, Jessica J; Kim, Sang-We; Solomon, Benjamin J; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Jürgen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul

Remote Monitoring and Data Collection for Decentralized Clinical Trials

远程监测和数据收集在分散式临床试验中的应用

Daly, Bobby; Brawley, Otis W; Gospodarowicz, Mary K; Olopade, Olufunmilayo I; Fashoyin-Aje, Lola; Smart, Victoria Wolodzko; Chang, I-Fen; Tendler, Craig L; Kim, Geoffrey; Fuchs, Charles S; Beg, Muhammad Shaalan; Zhang, Lianshan; Legos, Jeffrey J; Duran, Cristina Ortega; Kalidas, Chitkala; Qian, Jing; Finnegan, Justin; Pilarski, Piotr; Keane, Harriet; Shen, Johanna; Silverstein, Amy; Wu, Yi-Long; Pazdur, Richard; Li, Bob T

Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?

肿瘤学领域的去中心化临床试验:我们是否已准备好迎接虚拟优先模式?

Fu, Sherry; Gerber, David E; Beg, Muhammad Shaalan

Author Correction: Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

作者更正:难治性非结直肠胃肠道癌症中新出现的循环肿瘤DNA改变的遗传特征和治疗意义

Hsiehchen, David; Bucheit, Leslie; Yang, Dong; Beg, Muhammad Shaalan; Lim, Mir; Lee, Sunyoung S; Kasi, Pashtoon Murtaza; Kaseb, Ahmed O; Zhu, Hao

Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial

MUC5AC抗体(NPC-1C)联合二线吉西他滨和白蛋白紫杉醇治疗对晚期胰腺导管腺癌患者生存的影响:一项随机临床试验

Huffman, Brandon M; Basu Mallick, Atrayee; Horick, Nora K; Wang-Gillam, Andrea; Hosein, Peter Joel; Morse, Michael A; Beg, Muhammad Shaalan; Murphy, Janet E; Mavroukakis, Sharon; Zaki, Anjum; Schlechter, Benjamin L; Sanoff, Hanna; Manz, Christopher; Wolpin, Brian M; Arlen, Philip; Lacy, Jill; Cleary, James M

Survival of cancer survivors with a new pancreatic cancer diagnosis

新确诊胰腺癌的癌症幸存者的生存情况

Pruitt, Sandi L; Tavakkoli, Anna; Zhu, Hong; Heitjan, Daniel F; Gerber, David E; Singal, Amit G; Halm, Ethan A; Beg, Muhammad Shaalan; Maddineni, Bhumika; Kansagra, Ankit J; Murphy, Caitlin C

Rural-Urban Disparities in Mortality and Place of Death for Gastrointestinal Cancer in the United States From 2003 to 2019

2003年至2019年美国城乡胃肠道癌症死亡率和死亡地点差异

Hussaini, S M Qasim; Blackford, Amanda L; Arora, Nivedita; Sedhom, Ramy; Beg, Muhammad Shaalan; Gupta, Arjun

Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers

难治性非结直肠胃肠道癌症中新出现的循环肿瘤DNA改变的遗传特征和治疗意义

Hsiehchen, David; Bucheit, Leslie; Yang, Dong; Beg, Muhammad Shaalan; Lim, Mir; Lee, Sunyoung S; Kasi, Pashtoon Murtaza; Kaseb, Ahmed O; Zhu, Hao

A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer

可切除胆囊癌患者化疗使用倾向评分分析

Ozer, Muhammet; Goksu, Suleyman Y; Sanford, Nina N; Porembka, Matthew; Khurshid, Hajra; Ahn, Chul; Maxwell, Mary Claire; Beg, Muhammad Shaalan; Kazmi, Syed M

A qualitative study to explore the acceptability and usefulness of personalized biofeedback to motivate physical activity in cancer survivors

一项旨在探讨个性化生物反馈在激励癌症幸存者进行体育锻炼方面的可接受性和有效性的定性研究

Brannon, Grace E; Ray, Madison; Cho, Patrick; Baum, Miranda; Beg, Muhammad Shaalan; Bevers, Therese; Schembre, Susan M; Basen-Engquist, Karen; Liao, Yue